반응식
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[C:7]([N:10]1[CH2:19][CH2:18][C:17]2[C:12](=[CH:13][C:14]([S:20](Cl)(=[O:22])=[O:21])=[CH:15][CH:16]=2)[CH2:11]1)(=[O:9])[CH3:8].C(NC(C)C)(C)C.Cl.N1(S(C2C=C3C(CCNC3)=CC=2)(=O)=O)CCOCC1>C1COCC1>[C:7]([N:10]1[CH2:19][CH2:18][C:17]2[C:12](=[CH:13][C:14]([S:20]([N:1]3[CH2:6][CH2:5][O:4][CH2:3][CH2:2]3)(=[O:21])=[O:22])=[CH:15][CH:16]=2)[CH2:11]1)(=[O:9])[CH3:8]참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
was obtained as described in Example 4A by reacting morpholine with 2-acetyl-1,2,3,4-tetrahydroisoquinoline-7-sulfonyl chloride in the presence of diisopropylamine in THF and by heating with 50% concentrated hydrochloric acid and, after alkaline workup, converted into the corresponding 7-(morpholin-4-ylsulfonyl)-1,2,3,4-tetrahydroisoquinoline.
후처리
- customwas obtained
출처 및 근거
- ORD 기록
- ord-4465e0f4aed34412858468b27119c327
- 출처 데이터셋
- uspto-grants-2003_08
- 특허 번호
- US06602867B1
연결된 노트
불러오는 중…